Latest Capital Markets News

Vanadium Resources (ASX: VR8) has taken major steps to commercialise its Steelpoortdrift project with a non-binding offtake deal with U.S. Vanadium and appointed Rand Merchant Bank to lead funding efforts.

Zenith Minerals has reported a significant milestone with a maiden 675,000-ounce JORC Inferred Mineral Resource at its Consolidated Dulcie Gold Project, alongside deep drilling success at Red Mountain that extends mineralisation beyond 700 metres.

Cynata Therapeutics is on the cusp of releasing critical data from its Phase 2 aGvHD and Phase 3 osteoarthritis trials in Q2 2026, while managing a tight cash runway and preparing for a capital raising.

Mount Ridley Mines has reported a substantial inferred mineral resource for heavy rare earths and scandium at its Western Australian project, underpinning its multi-element development strategy.

Titomic Limited is gearing up for a strategic shift to the US with a planned redomicile in H2 2026, while clinching major contracts across aerospace, defense, and rail sectors and achieving critical certifications that underpin its manufacturing ambitions.

4DMedical has made significant strides in commercial adoption of its CT:VQ™ lung imaging technology, securing top US hospital contracts, regulatory approvals in Europe and the UK, and a major pharmaceutical partnership, all backed by strong capital raises and inclusion in the S&P/ASX 200.

Atomic Eagle Limited has boosted its Muntanga Uranium Project resources by 24%, declared a maiden Ore Reserve, and confirmed project viability through an independent engineering review, setting the stage for a major drilling campaign.

Sunstone Metals reported robust growth at its Bramaderos gold-copper project with a 3.6Moz AuEq resource and substantial exploration targets. Drilling at Copete and Porotillo prospects confirmed mineralisation continuity, underpinning potential resource upgrades.

Hot Chili Limited secured A$40 million in a private placement to fast-track development of its Costa Fuego copper-gold project in Chile, buoyed by significant high-grade drill results extending the La Verde discovery footprint.

BlinkLab has completed onboarding all clinical sites for its pivotal FDA autism trial, enrolled the first participant, and launched a nationwide autism screening program in Morocco. A recent A$17.7 million capital raise will fund further trials and expansion into ADHD diagnostics.

AdAlta has launched its East-to-West cellular immunotherapy strategy through a co-development deal for CAR-T therapy BZDS1901, showing promising complete tumour clearance in mesothelioma patients and transferring manufacturing to Australia to boost scalability.

Chalice Mining has bolstered its leadership and financing strategy while advancing a Feasibility Study for its Gonneville palladium-nickel-copper project, amid improving market conditions and promising exploration results.